ACCESSION: MSBNK-SMB_Measured-HSA014P0242000
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; NEGATIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 80
COMMENT: RAW_SPEC {'Blanc1-neg_7358': {'bp': 1189962.0, 'sum': 2456066.0}, 'Blanc1-neg_7394': {'bp': 1051572.0, 'sum': 2224378.0}, 'Blanc1-neg_7324': {'bp': 190487.0, 'sum': 479021.0}, 'EL11-neg_6468': {'bp': 173556.0, 'sum': 415834.0}, 'EL07-neg_6486': {'bp': 170880.0, 'sum': 352979.0}, 'EL05-neg_6502': {'bp': 168515.0, 'sum': 377114.0}, 'EL17-neg_6492': {'bp': 165952.0, 'sum': 374467.0}, 'EL06-neg_6503': {'bp': 165830.0, 'sum': 368823.0}, 'EL24-neg_6464': {'bp': 163757.0, 'sum': 354899.0}, 'EL09-neg_6484': {'bp': 158240.0, 'sum': 352817.0}, 'EL02-neg_6540': {'bp': 158184.0, 'sum': 361611.0}, 'EL23-neg_6475': {'bp': 155764.0, 'sum': 337165.0}, 'EL08-neg_6470': {'bp': 151738.0, 'sum': 338823.0}, 'EL22-neg_6522': {'bp': 147998.0, 'sum': 338560.0}, 'EL19-neg_6516': {'bp': 145840.0, 'sum': 330970.0}, 'EL13-neg_6470': {'bp': 144018.0, 'sum': 317597.0}, 'EL10-neg_6485': {'bp': 142533.0, 'sum': 299719.0}, 'EL16-neg_6471': {'bp': 142383.0, 'sum': 302422.0}, 'EL04-neg_6461': {'bp': 138738.0, 'sum': 304421.0}, 'EL01-neg_6467': {'bp': 137493.0, 'sum': 318452.0}, 'EL03-neg_6466': {'bp': 136299.0, 'sum': 300788.0}, 'EL12-neg_6512': {'bp': 135092.0, 'sum': 307391.0}, 'Blanc2-neg_6434': {'bp': 134426.0, 'sum': 295521.0}, 'EL15-neg_6491': {'bp': 132913.0, 'sum': 311194.0}, 'EL18-neg_6480': {'bp': 132375.0, 'sum': 299768.0}, 'Blanc1-neg_7431': {'bp': 131493.0, 'sum': 316129.0}, 'EL21-neg_6493': {'bp': 128236.0, 'sum': 291601.0}, 'EL20-neg_6496': {'bp': 125788.0, 'sum': 299704.0}, 'EL14-neg_6488': {'bp': 125188.0, 'sum': 285277.0}, 'Blanc3-neg_6449': {'bp': 120340.0, 'sum': 255730.0}, 'EL11-neg_6501': {'bp': 76198.0, 'sum': 178217.0}, 'EL08-neg_6503': {'bp': 75598.0, 'sum': 177320.0}, 'EL14-neg_6454': {'bp': 75562.0, 'sum': 187079.0}, 'EL02-neg_6508': {'bp': 71301.0, 'sum': 161840.0}, 'Blanc3-neg_6418': {'bp': 70164.0, 'sum': 170690.0}, 'EL07-neg_6517': {'bp': 68729.0, 'sum': 168179.0}, 'EL20-neg_6463': {'bp': 68592.0, 'sum': 176863.0}, 'EL22-neg_6490': {'bp': 67358.0, 'sum': 169775.0}, 'EL21-neg_6457': {'bp': 67188.0, 'sum': 184727.0}, 'EL24-neg_6428': {'bp': 67178.0, 'sum': 173609.0}, 'EL03-neg_6498': {'bp': 65547.0, 'sum': 151355.0}, 'EL04-neg_6429': {'bp': 63606.0, 'sum': 152931.0}, 'EL23-neg_6441': {'bp': 63119.0, 'sum': 146190.0}, 'EL11-neg_6436': {'bp': 62992.0, 'sum': 157511.0}, 'EL01-neg_6500': {'bp': 62870.0, 'sum': 127593.0}, 'EL02-neg_6573': {'bp': 61216.0, 'sum': 154903.0}, 'EL17-neg_6456': {'bp': 60832.0, 'sum': 150478.0}, 'EL19-neg_6553': {'bp': 59792.0, 'sum': 145618.0}, 'EL09-neg_6452': {'bp': 58579.0, 'sum': 154388.0}, 'EL07-neg_6450': {'bp': 58509.0, 'sum': 144610.0}, 'EL12-neg_6477': {'bp': 58003.0, 'sum': 160386.0}, 'EL19-neg_6485': {'bp': 56960.0, 'sum': 146560.0}, 'EL16-neg_6504': {'bp': 56819.0, 'sum': 141933.0}, 'EL04-neg_6493': {'bp': 55594.0, 'sum': 143733.0}, 'EL10-neg_6450': {'bp': 55579.0, 'sum': 145099.0}, 'EL06-neg_6468': {'bp': 52392.0, 'sum': 134456.0}, 'EL12-neg_6544': {'bp': 51682.0, 'sum': 133574.0}, 'EL15-neg_6527': {'bp': 51085.0, 'sum': 125067.0}, 'EL17-neg_6527': {'bp': 50272.0, 'sum': 124449.0}, 'Blanc2-neg_6403': {'bp': 50008.0, 'sum': 129188.0}, 'EL05-neg_6467': {'bp': 49859.0, 'sum': 141842.0}, 'EL09-neg_6520': {'bp': 49106.0, 'sum': 124326.0}, 'Blanc2-neg_6471': {'bp': 49081.0, 'sum': 115052.0}, 'EL08-neg_6438': {'bp': 47538.0, 'sum': 123838.0}, 'EL06-neg_6540': {'bp': 46856.0, 'sum': 126726.0}, 'EL16-neg_6440': {'bp': 46040.0, 'sum': 131148.0}, 'EL15-neg_6458': {'bp': 46032.0, 'sum': 112463.0}, 'EL23-neg_6508': {'bp': 45217.0, 'sum': 112211.0}, 'EL05-neg_6544': {'bp': 45184.0, 'sum': 114249.0}, 'EL13-neg_6435': {'bp': 44490.0, 'sum': 116894.0}, 'EL01-neg_6434': {'bp': 43943.0, 'sum': 107236.0}, 'EL18-neg_6446': {'bp': 43307.0, 'sum': 115159.0}, 'EL20-neg_6529': {'bp': 40860.0, 'sum': 105373.0}, 'EL13-neg_6509': {'bp': 40638.0, 'sum': 114307.0}, 'EL18-neg_6519': {'bp': 40344.0, 'sum': 107833.0}, 'EL03-neg_6434': {'bp': 39931.0, 'sum': 105678.0}, 'EL24-neg_6499': {'bp': 39799.0, 'sum': 94708.0}, 'Blanc3-neg_6483': {'bp': 33400.0, 'sum': 90473.0}, 'EL21-neg_6532': {'bp': 29465.0, 'sum': 82017.0}, 'EL22-neg_6566': {'bp': 27823.0, 'sum': 93962.0}}
COMMENT: RETENTION_TIME_STDEV 0.288
COMMENT: PRECURSOR_M/Z_RAW 242.175827
COMMENT: PRECURSOR_M/Z_STDEV 0.000094
COMMENT: PRECURSOR_IN_MS1 mz 242.176121; int 47.429; delta(ppm) 1.021887
COMMENT: PROPOSED_CHARGE_STATE -1; mz 243.179602; int 6.621; cor 0.936
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.206; C13H25NO3; [M-H]1; delta(ppm) -0.205606
COMMENT: PROPOSED_MF MS-FINDER 3.862; C13H25NO3; [M-H]-; delta(ppm) -0.203319
COMMENT: PROPOSED_MF SIRIUS5_Sirius 12.302; C13H25NO3; [M-H]-; delta(ppm) -0.203319
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C13H25NO3; [M-H]-; delta(ppm) -0.203319
COMMENT: PROPOSED_MF SIRIUS6_Sirius 19.887; C13H25NO3; [M-H]-; delta(ppm) -0.203319
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.600; C11H23N4O2; [M-H]-; delta(ppm) 5.340871
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.999; C13H25NO3; [M-H]-; delta(ppm) -0.203319
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C11H23N4O2; [M-H]-; delta(ppm) 5.340871
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.198; KWMRFDVSMVGRLI-UHFFFAOYSA-N; [M-H]-; OCC1(CNCC2CCCC2)CC(O)C(O)C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.833; HEUQYIQQCNOXOG-UHFFFAOYSA-N; [M-H]-; CCCCCCCCCCC(=O)NCC(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.569; GSYSEQUYQXPNHH-WEUYFXHZNA-N; [M-H]-; CC(C)OC(=O)[C@H](O)[C@@H](N)CC1CCCCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.419; WMCLKPGRHOQJAI-UHFFFAOYSA-N; [M-H]-; O=C(N(CCCO)C1CCOC(C)(C)C1)CC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.403; PGJJWEQJZIWKQY-QWAQRTLVNA-N; [M-H]-; CCOC(=O)[C@@]1(CCCC[C@@]1(O)CC)N(C)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.394; GSYSEQUYQXPNHH-WEUYFXHZNA-N; [M-H]-; CYCLOHEXYL-NORSTATINE
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.154; HEUQYIQQCNOXOG-UHFFFAOYSA-N; [M-H]-; N-Undecanoylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.023; BORDUPYPIRUXNW-NVHKGDCHNA-N; [M-H]-; UNPD186376
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.023; PGJJWEQJZIWKQY-QWAQRTLVNA-N; [M-H]-; UNPD49763
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.975; KWMRFDVSMVGRLI-UHFFFAOYSA-N; [M-H]-; 4-{[(cyclopentylmethyl)amino]methyl}-4-(hydroxymethyl)cyclopentane-1,2-diol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.936; WMCLKPGRHOQJAI-UHFFFAOYSA-N; [M-H]-; N-(2,2-dimethyloxan-4-yl)-N-(3-hydroxypropyl)propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; GSYSEQUYQXPNHH-WEUYFXHZNA-N; [M-H]-; CYCLOHEXYL-NORSTATINE
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.239; HEUQYIQQCNOXOG-UHFFFAOYSA-N; [M-H]-; N-Undecanoylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.239; BORDUPYPIRUXNW-NVHKGDCHNA-N; [M-H]-; UNPD186376
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.239; PGJJWEQJZIWKQY-QWAQRTLVNA-N; [M-H]-; UNPD49763
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.239; KWMRFDVSMVGRLI-UHFFFAOYSA-N; [M-H]-; 4-{[(cyclopentylmethyl)amino]methyl}-4-(hydroxymethyl)cyclopentane-1,2-diol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.239; WMCLKPGRHOQJAI-UHFFFAOYSA-N; [M-H]-; N-(2,2-dimethyloxan-4-yl)-N-(3-hydroxypropyl)propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.141; HEUQYIQQCNOXOG-UHFFFAOYSA-N; [M-H]-; 2-(undecanoylamino)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.500; OXPWHPCCUXESFQ-UHFFFAOYSA-N; [M-H]-; tert-butyl 4-(3-hydroxypropyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.611; YNBRORWNNGUYQA-NSHDSACASA-N; [M-H]-; tert-butyl N-[(1R)-1-cyclohexyl-2-hydroxyethyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.604; DIQOZPGKFVICKN-UHFFFAOYSA-N; [M-H]-; tert-butyl 3-(3-hydroxypropyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.558; NJXIJKXUFFXDMC-UHFFFAOYSA-N; [M-H]-; tert-butyl N-(8-oxooctyl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.547; ZLEBLWDLKHDYEW-UHFFFAOYSA-N; [M-H]-; tert-butyl N-(1-cyclopentyl-3-hydroxypropan-2-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.530; HLSJFBQWCBNSQQ-UHFFFAOYSA-N; [M-H]-; tert-butyl 4-(2-hydroxyethyl)-2,2-dimethylpyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.511; VCIBBCGSWUMTGW-UHFFFAOYSA-N; [M-H]-; tert-butyl N-[[2-(hydroxymethyl)cyclohexyl]methyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.500; ASVYJCJXBYNYKQ-UHFFFAOYSA-N; [M-H]-; tert-butyl N-(5,5-dimethyl-1-oxohexan-3-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.500; DBWREWKJBLECNR-MNOVXSKESA-N; [M-H]-; tert-butyl N-[[(1R,3S)-3-(hydroxymethyl)cyclohexyl]methyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.517; YXZJRETWUVFEFX-ZJUUUORDSA-N; [M-H]-; tert-butyl (2S,4R)-4-[(2-methylpropan-2-yl)oxy]pyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; CSBKKQVPRRRVQQ-UHFFFAOYSA-N; [M-H]-; heptyl 2-(diethylamino)-2-oxoacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; VXKVVXXJHGUYAQ-UHFFFAOYSA-N; [M-H]-; 6-[3-(2-ethoxyethoxy)propyl]-8-oxa-6-azabicyclo[3.2.1]octane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -192.621; HEUQYIQQCNOXOG; [M-H]-; acylglycine C:11
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.511; GSYSEQUYQXPNHH; [M-H]-; propan-2-yl 3-amino-4-cyclohexyl-2-hydroxybutanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -250.123; SZUMGHGZFKDFPU; [M-H]-; 3-methyl-2-(octanoylamino)butanoic Acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -302.349; YNBRORWNNGUYQA; [M-H]-; N-Boc-D-cyclohexylglycinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -316.363; NJXIJKXUFFXDMC; [M-H]-; Carbamic acid, (8-oxooctyl)-, 1,1-dimethylethyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -321.185; ZZAPENIYDFOWME; [M-H]-; Ethyl N-(2,3-dimethyl-2-isopropyl-1-oxobutyl)glycinate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -324.905; CSBKKQVPRRRVQQ; [M-H]-; Heptyl N,N-diethyloxamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -329.885; OXPWHPCCUXESFQ; [M-H]-; Boc-4-Piperidinepropanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -339.474; KWMRFDVSMVGRLI; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -398.256; VXKVVXXJHGUYAQ; [M-H]-; 6-[3-(2-ethoxyethoxy)propyl]-8-oxa-6-azabicyclo[3.2.1]octane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -406.277; WMCLKPGRHOQJAI; [M-H]-; N-(2,2-dimethyloxan-4-yl)-N-(3-hydroxypropyl)propanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -413.437; JTKDORYHWJDUAS; [M-H]-; 1-(4,4-Diethoxybutyl)piperidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -439.753; BORDUPYPIRUXNW; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -454.429; PGJJWEQJZIWKQY; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.187; HEUQYIQQCNOXOG; [M-H]-; acylglycine C:11
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -304.304; HEUQYIQQCNOXOG; [M-H]-; 2-undecanamidoacetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -351.106; NJXIJKXUFFXDMC; [M-H]-; tert-Butyl 8-oxooctylcarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -380.897; OXPWHPCCUXESFQ; [M-H]-; Tert-butyl 4-(3-hydroxypropyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -383.447; SZUMGHGZFKDFPU; [M-H]-; N-Octanoyl-L-valine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -406.811; ZLEBLWDLKHDYEW; [M-H]-; tert-butyl N-[(2R)-1-cyclopentyl-3-hydroxypropan-2-yl]carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -411.159; VXKVVXXJHGUYAQ; [M-H]-; 6-(3-(2-Ethoxyethoxy)propyl)-8-oxa-6-azabicyclo(3.2.1)octane
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -416.727; KWMRFDVSMVGRLI; [M-H]-; 4-{[(cyclopentylmethyl)amino]methyl}-4-(hydroxymethyl)cyclopentane-1,2-diol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -418.285; YNBRORWNNGUYQA; [M-H]-; N-Boc-D-cyclohexylglycinol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -433.495; GSYSEQUYQXPNHH; [M-H]-; Cyclohexyl-norstatine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -455.917; DBWREWKJBLECNR; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.266; HEUQYIQQCNOXOG; [M-H]-; 2-undecanamidoacetic acid
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C13H24N1O3; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 11.185
MS$FOCUSED_ION: PRECURSOR_M/Z 242.176118
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0006-0290000000-95b4f5cebccd5724665f
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  181.1587626 352.0701 181.158980 0.8501 37.19 0.9607 79 f{C12H21O1}/-5.67ppm,p-C1H3N1O2
  224.1656689 53.1775 224.165390 1.6729 11.20 0.9166 60 f{C13H22N1O2}/0.30ppm,p-H2O1
  225.1495872 336.9338 225.149320 0.8572 39.25 0.9425 79 f{C13H21O3}/-0.14ppm,p-H3N1
  242.1761163 999.0000 242.176070 0.4583 0.00 1.0000 80 f{C13H24N1O3}/-0.21ppm,p
PK$NUM_PEAK: 4
PK$PEAK: m/z int. rel.int.
  181.158763 352.07 352
  224.165669 53.18 53
  225.149587 336.93 336
  242.176116 999.00 999
//
